Rapidly Progressive Renal Failure in AA Amyloidosis: A New Clinical and Histopathological Entity for an Old Disease

dc.contributor.authorCelebi, Zeynep Kendi
dc.contributor.authorKiremitci, Saba
dc.contributor.authorSadioglu, Rezzan Eren
dc.contributor.authorKeven, Kenan
dc.contributor.orcID0000-0003-3279-9796en_US
dc.contributor.researcherIDABB-9570-2020en_US
dc.date.accessioned2021-04-19T12:03:26Z
dc.date.available2021-04-19T12:03:26Z
dc.date.issued2020
dc.description.abstractObjective: Secondary renal AA amyloidosis (RAAA) presents with proteinuria and/or as nephrotic syndrome and progresses to end stage renal disease (ESRD) insidiously. However, some patients with secondary amyloidosis show a more rapid renal disease progression than the usual course. In this study, we aimed to investigate the underlying cause of the rapidly progressive renal disease in the patients with secondary amyloidosis. Materials and Methods: Patients with kidney biopsy proven secondary RAAA were divided into 2 groups: the rapidly progressive group (estimated glomerular filtration rate >60 mL/min, who needed renal replacement therapy within one year of diagnosis) and the control group. Biopsy specimens were reevaluated for glomerular-vascular amyloid load, tubular atrophy, interstitial fibrosis, and interstitial inflammation. The biopsy characteristics and biochemical parameters were compared between the groups. Results: Histopathological examination showed global amyloid deposition, vascular pole involvement, peritubular capillary amyloid deposition, and severe interstitial inflammation associated with rapidly progressive disease. Estimated glomerular filtration rate was lower and proteinuria was higher in the rapidly progressive group than in the control group. Vascular pole amyloid deposition was found to be a predictor of ESRD in multivariate analysis. Conclusion: This study shows that higher amyloid deposition and severe inflammation revealed in in kidney biopsy of secondary RAAA cases can be risk factors for rapidly progressive renal failure.en_US
dc.identifier.eissn2667-4440en_US
dc.identifier.endpage296en_US
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85095877538en_US
dc.identifier.startpage289en_US
dc.identifier.urihttps://turkjnephrol.org/en/rapidly-progressive-renal-failure-in-aa-amyloidosis-a-new-clinical-and-histopathological-entity-for-an-old-disease-136914
dc.identifier.urihttp://hdl.handle.net/11727/5750
dc.identifier.volume29en_US
dc.identifier.wos000581947700006en_US
dc.language.isoengen_US
dc.relation.isversionof10.5152/turkjnephrol.2020.4221en_US
dc.relation.journalTURKISH JOURNAL OF NEPHROLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAmyloidosisen_US
dc.subjectbiopsyen_US
dc.subjectkidneyen_US
dc.subjectkidney failureen_US
dc.titleRapidly Progressive Renal Failure in AA Amyloidosis: A New Clinical and Histopathological Entity for an Old Diseaseen_US
dc.typearticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
289-296.pdf
Size:
635.6 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: